Nov 10 (Reuters)-
Garna Biosciences Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2017 Sep 30, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 483 mln 581 mln 701 mln
(-16.8 pct) (-54.5 pct) (-13.5 pct)
Operating loss 477 mln loss 334 mln loss 727 mln
Recurring loss 486 mln loss 352 mln loss 738 mln
Net loss 508 mln loss 178 mln loss 766 mln
EPS loss 54.46 yen loss 19.52 yen loss 82.12 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Garna Biosciences Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T
((Tokyo Headline News Desk +813 6441 1812))